Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Argiles

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Science (London, England : 1979)|May 1, 1989
High-molecular-mass proteins in haemodialysis-associated amyloidosisA Argiles, G Mourad, C Axelrud-Cavadore, et al.
Transplantation Proceedings|December 1, 1992
Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietinG Mourad, J P Cristol, G Chong, et al.
Nephron|January 1, 1992
Measurement of vascular access recirculation without contralateral venous punctureM Thomas, A Argiles, P G Kerr, et al.
Nephron|January 1, 1987
Dialysis-associated amyloidosis in a patient on long-term post-dilutional hemofiltrationA Argiles, G Mourad, P Berta, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 12, 1998
On-line haemodiafiltration: state of the artB Canaud, J Y Bosc, H Leray, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
Haemodiafiltration in high-cardiovascular-risk patientsM Mion, P G Kerr, A Argiles, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2000
On-line haemodiafiltration. Safety and efficacy in long-term clinical practiceB Canaud, J Y Bosc, H Leray-Moragues, et al.
Investigative Ophthalmology & Visual Science|May 8, 2000
BIGH3 exon 14 mutations lead to intermediate type I/IIIA of lattice corneal dystrophiesC F Schmitt-Bernard, C Guittard, B Arnaud, et al.
Biochemical and Biophysical Research Communications|June 30, 2000
In vitro creation of amyloid fibrils from native and Arg124Cys mutated betaIGH3((110-131)) peptides, and its relevance for lattice corneal amyloid dystrophy type IC F Schmitt-Bernard, A Chavanieu, J Derancourt, et al.
Clinical Science (London, England : 1979)|November 1, 1987
Haemodialysis-associated amyloidosis: beta 2-microglobulin alone or associated with globin chains?A Argiles, G Mourad, C Axelrud-Cavadore, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Science (London, England : 1979)|May 1, 1989
High-molecular-mass proteins in haemodialysis-associated amyloidosisA Argiles, G Mourad, C Axelrud-Cavadore, et al.
Transplantation Proceedings|December 1, 1992
Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietinG Mourad, J P Cristol, G Chong, et al.
Nephron|January 1, 1992
Measurement of vascular access recirculation without contralateral venous punctureM Thomas, A Argiles, P G Kerr, et al.
Nephron|January 1, 1987
Dialysis-associated amyloidosis in a patient on long-term post-dilutional hemofiltrationA Argiles, G Mourad, P Berta, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 12, 1998
On-line haemodiafiltration: state of the artB Canaud, J Y Bosc, H Leray, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
Haemodiafiltration in high-cardiovascular-risk patientsM Mion, P G Kerr, A Argiles, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2000
On-line haemodiafiltration. Safety and efficacy in long-term clinical practiceB Canaud, J Y Bosc, H Leray-Moragues, et al.
Investigative Ophthalmology & Visual Science|May 8, 2000
BIGH3 exon 14 mutations lead to intermediate type I/IIIA of lattice corneal dystrophiesC F Schmitt-Bernard, C Guittard, B Arnaud, et al.
Biochemical and Biophysical Research Communications|June 30, 2000
In vitro creation of amyloid fibrils from native and Arg124Cys mutated betaIGH3((110-131)) peptides, and its relevance for lattice corneal amyloid dystrophy type IC F Schmitt-Bernard, A Chavanieu, J Derancourt, et al.
Clinical Science (London, England : 1979)|November 1, 1987
Haemodialysis-associated amyloidosis: beta 2-microglobulin alone or associated with globin chains?A Argiles, G Mourad, C Axelrud-Cavadore, et al.
Pageof 4